Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) stock analysis

RARE · Ultragenyx Pharmaceutical Inc. - Common Stock

Latest recorded price: USD 15.90

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 22.8%, free cash flow margin -70.1%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare